Pfizer COVID-19 Pill 89% Effective in Reducing Hospitalization and Death
If the FDA grants emergency use authorization for the drug, it could become available in the U.S. by next year

Pfizer has been conducting a randomized, double-blind study of their antiviral pill to a cohort of 1,881 non-hospitalized adult patients with COVID-19. They…